These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 18383821)
1. Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein (RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography. Hsieh TC; Wang Z; Deng H; Wu JM Anticancer Res; 2008; 28(1A):29-36. PubMed ID: 18383821 [TBL] [Abstract][Full Text] [Related]
2. Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography. Wang Z; Hsieh TC; Zhang Z; Ma Y; Wu JM Biochem Biophys Res Commun; 2004 Oct; 323(3):743-9. PubMed ID: 15381063 [TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells. Hsieh TC Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Aziz MH; Nihal M; Fu VX; Jarrard DF; Ahmad N Mol Cancer Ther; 2006 May; 5(5):1335-41. PubMed ID: 16731767 [TBL] [Abstract][Full Text] [Related]
6. Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4'-amino-3,5-dihydroxy-trans-stilbene. Ito Y; Mitani T; Harada N; Isayama A; Tanimori S; Takenaka S; Nakano Y; Inui H; Yamaji R J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):358-64. PubMed ID: 24064738 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol: Biological and pharmaceutical properties as anticancer molecule. Hsieh TC; Wu JM Biofactors; 2010; 36(5):360-9. PubMed ID: 20623546 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Lançon A; Hanet N; Jannin B; Delmas D; Heydel JM; Lizard G; Chagnon MC; Artur Y; Latruffe N Drug Metab Dispos; 2007 May; 35(5):699-703. PubMed ID: 17287390 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells. Harada N; Murata Y; Yamaji R; Miura T; Inui H; Nakano Y J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):556-60. PubMed ID: 18202547 [TBL] [Abstract][Full Text] [Related]
10. Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2. Hsieh TC; Lin CY; Bennett DJ; Wu E; Wu JM PLoS One; 2014; 9(6):e101070. PubMed ID: 24968355 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluation. Narayanan NK; Narayanan BA; Nixon DW Cancer Detect Prev; 2004; 28(6):443-52. PubMed ID: 15582268 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Bhat KP; Pezzuto JM Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064 [TBL] [Abstract][Full Text] [Related]
14. The Resveratrol Tetramer r-Viniferin Induces a Cell Cycle Arrest Followed by Apoptosis in the Prostate Cancer Cell Line LNCaP. Empl MT; Albers M; Wang S; Steinberg P Phytother Res; 2015 Oct; 29(10):1640-5. PubMed ID: 26331691 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer. Kumar A; Dhar S; Rimando AM; Lage JM; Lewin JR; Zhang X; Levenson AS Ann N Y Acad Sci; 2015 Aug; 1348(1):1-9. PubMed ID: 26214308 [TBL] [Abstract][Full Text] [Related]
16. Anti-estrogenic activity of a human resveratrol metabolite. Ruotolo R; Calani L; Fietta E; Brighenti F; Crozier A; Meda C; Maggi A; Ottonello S; Del Rio D Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1086-92. PubMed ID: 23465317 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis. Kuwajerwala N; Cifuentes E; Gautam S; Menon M; Barrack ER; Reddy GP Cancer Res; 2002 May; 62(9):2488-92. PubMed ID: 11980638 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Murias M; Miksits M; Aust S; Spatzenegger M; Thalhammer T; Szekeres T; Jaeger W Cancer Lett; 2008 Mar; 261(2):172-82. PubMed ID: 18082939 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of quinone reductase 2 in complex with resveratrol. Buryanovskyy L; Fu Y; Boyd M; Ma Y; Hsieh TC; Wu JM; Zhang Z Biochemistry; 2004 Sep; 43(36):11417-26. PubMed ID: 15350128 [TBL] [Abstract][Full Text] [Related]
20. Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells. Hsieh TC Asian J Androl; 2009 Nov; 11(6):653-61. PubMed ID: 19767760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]